cas 2869955-99-5|| where to buy tert-butyl 4-(1-methoxy-1,3-dioxopentan-2-yl)piperazine-1-carboxylate

Nombre del producto:tert-butyl 4-(1-methoxy-1,3-dioxopentan-2-yl)piperazine-1-carboxylate

IUPAC Name:tert-butyl 4-(1-methoxy-1,3-dioxopentan-2-yl)piperazine-1-carboxylate

Unidad de embalaje	Stock disponible	Precio($)
CM1078120-100mg	in stock	ȀňŔ
CM1078120-500mg	in stock	ƄȀƞň
CM1078120-1g	in stock	źƞŢȀ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2869955-99-5 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2869955-99-5; Fórmula molecular:C15H26N2O5; Punto de fusión:-; Código de sonrisas:O=C(OC(C)(C)C)N1CCN(CC1)C(C(=O)OC)C(=O)CC; Densidad:1.130±0.06 g/cm3

: Número de catálogo:CM1078120; Peso molecular:314.38; Punto de ebullición:397.8±42.0 °C; Nº Mdl:; Almacenamiento:

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: HRO761; Novartis'HRO761 is an oral allosteric inhibitor targeting WRN helicase, aimed at treating microsatellite instability (MSI) or deficient mismatch repair (dMMR) tumors. WRN has emerged as a critical synthetic lethal target in MSI cancers, which are common in colorectal, gastric, endometrial, and ovarian cancers. Although MSI cancers show a high response rate to immune checkpoint inhibitors, many patients develop resistance. By acting on WRN, HRO761 may be able to stop the growth of the cancer.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.